|

CD19-CAR(Mem) T-cells Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1: 1

Top Sponsors

  • St. Jude Children's Research Hospital1

Indications

  • Acute Lymphoblastic Leukemia, Refractory1
  • Acute Lymphoblastic Leukemia, in Relapse1
  • Pediatric ALL1
  • Cancer1

Memphis, Tennessee1 trial

Study of CD19-directed Allogeneic Memory T-cell Therapy for Relapsed/Refractory CD19+ Leukemia

St. Jude Children's Research Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.